AKERO THERAPEUTICS, INC. - Common Stock (AKRO)

CUSIP: 00973Y108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
82,872,659
Total 13F shares
20,018
Share change
-91,333,932
Total reported value
$532,984
Price per share
$40.63
Number of holders
2
Value change
-$4,336,826,803
Number of buys
1
Number of sells
255

Quarterly Holders Quick Answers

What is CUSIP 00973Y108?
CUSIP 00973Y108 identifies AKRO - AKERO THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q4 2025

As of 31 Dec 2025, AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,018 shares. The largest 2 holders included DekaBank Deutsche Girozentrale and IFP Advisors, Inc. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.